Clinical Outcomes and Adherence to Medications Measured by Claims Data in Patients with Diabetes

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2004 Nov 25

PMID 15562188

Citations 170

Authors

Manel Pladevall

L Keoki Williams

Lisa Ann Potts

George Divine

Hugo Xi

Jennifer Elston Lafata

Affiliations

Soon will be listed here.

Abstract

Objective: Although poor medication adherence may contribute to inadequate diabetes control, ways to feasibly measure adherence in routine clinical practice have yet to be established. The present study was conducted to determine whether pharmacy claims-based measures of medication adherence are associated with clinical outcomes in patients with diabetes.

Research Design And Methods: The study setting was a large, integrated delivery and financial system serving the residents of southeastern Michigan. The study population consisted of 677 randomly selected patients aged > or =18 years with a diagnosis of diabetes, hypercholesterolemia, and hypertension and who filled at least one prescription for either an antidiabetic, lipid-lowering, or antihypertensive drug in each of the 3 study years (1999-2001). The main outcome measures were HbA1c, LDL cholesterol levels, and blood pressure.

Results: Nonadherent patients had both statistically and clinically worse outcomes than adherent patients. Even after adjusting for demographic and clinical characteristics, nonadherence was significantly associated with HbA1c and LDL cholesterol levels. A 10% increase in nonadherence to metformin and statins was associated with an increase of 0.14% in HbA1c and an increase of 4.9 mg/dl in LDL cholesterol levels. Nonadherence to ACE inhibitors was not significantly associated with blood pressure.

Conclusions: Claims-based measures of medication adherence are associated with clinical outcomes in patients with diabetes and may therefore prove to be useful in clinical practice. More research is needed on methods to introduce claims-based adherence measurements into routine clinical practice and how to use these measurements to effectively improve adherence and health outcomes in chronic care management.

Citing Articles

Assessment of adherence to dietary recommendations and associated factors among type 2 diabetic patients in selected hospitals in Addis Ababa, Ethiopia.

Atinafu W, Tilahun K Front Nutr. 2025; 11:1474445.

PMID: 39995445 PMC: 11847667. DOI: 10.3389/fnut.2024.1474445.

Association between self-care activities and glycemic control among patients with type 2 diabetes mellitus in Northwest Ethiopia general hospitals : a multicenter cross-sectional study.

Wondm S, Zeleke T, Dagnew S, Moges T, Tarekegn G, Belachew E Sci Rep. 2024; 14(1):23198.

PMID: 39369010 PMC: 11455904. DOI: 10.1038/s41598-024-72981-0.

Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis.

Boonpattharatthiti K, Songkla P, Chantara J, Koomsri C, Krass I, Chaiyakunapruk N J Diabetes Investig. 2024; 15(11):1614-1625.

PMID: 39133204 PMC: 11527837. DOI: 10.1111/jdi.14285.

A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes-2nd Edition (English version).

Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H Diabetol Int. 2024; 15(3):327-345.

PMID: 39101173 PMC: 11291844. DOI: 10.1007/s13340-024-00723-8.

2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association.

Moon J, Kang S, Choi J, Lee K, Moon J, Chon S Diabetes Metab J. 2024; 48(4):546-708.

PMID: 39091005 PMC: 11307112. DOI: 10.4093/dmj.2024.0249.

References

Nichols G, Hillier T, Javor K, Brown J . Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care. 2000; 23(3):273-7. DOI: 10.2337/diacare.23.3.273. View

Hughes D, Bagust A, Haycox A, Walley T . The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ. 2001; 10(7):601-15. DOI: 10.1002/hec.609. View

Roter D, Hall J, Merisca R, Nordstrom B, Cretin D, Svarstad B . Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998; 36(8):1138-61. DOI: 10.1097/00005650-199808000-00004. View

Bodenheimer T, Wagner E, Grumbach K . Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002; 288(15):1909-14. DOI: 10.1001/jama.288.15.1909. View

Schiff G, Rucker T . Computerized prescribing: building the electronic infrastructure for better medication usage. JAMA. 1998; 279(13):1024-9. DOI: 10.1001/jama.279.13.1024. View

Steiner J, Prochazka A . The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997; 50(1):105-16. DOI: 10.1016/s0895-4356(96)00268-5. View

DiMatteo M, Sherbourne C, Hays R, Ordway L, Kravitz R, McGlynn E . Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol. 1993; 12(2):93-102. DOI: 10.1037/0278-6133.12.2.93. View

Kolodner K, Lipton R, Lafata J, Leotta C, Liberman J, Chee E . Pharmacy and medical claims data identified migraine sufferers with high specificity but modest sensitivity. J Clin Epidemiol. 2004; 57(9):962-72. DOI: 10.1016/j.jclinepi.2004.01.014. View

Cramer J . A systematic review of adherence with medications for diabetes. Diabetes Care. 2004; 27(5):1218-24. DOI: 10.2337/diacare.27.5.1218. View

10.

DiMatteo M . Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004; 42(3):200-9. DOI: 10.1097/01.mlr.0000114908.90348.f9. View

11.

Rosen M, Rigsby M, Salahi J, Ryan C, Cramer J . Electronic monitoring and counseling to improve medication adherence. Behav Res Ther. 2004; 42(4):409-22. DOI: 10.1016/S0005-7967(03)00149-9. View

12.

Saydah S, Fradkin J, Cowie C . Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004; 291(3):335-42. DOI: 10.1001/jama.291.3.335. View

13.

Schectman J, Schorling J, Nadkarni M, Voss J . Can prescription refill feedback to physicians improve patient adherence?. Am J Med Sci. 2004; 327(1):19-24. DOI: 10.1097/00000441-200401000-00005. View

14.

Farley J, Hines S, Musk A, Ferrus S, Tepper V . Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr. 2003; 33(2):211-8. DOI: 10.1097/00126334-200306010-00016. View

15.

Heisler M, Smith D, Hayward R, Krein S, Kerr E . How well do patients' assessments of their diabetes self-management correlate with actual glycemic control and receipt of recommended diabetes services?. Diabetes Care. 2003; 26(3):738-43. DOI: 10.2337/diacare.26.3.738. View

16.

Gray A, Clarke P, Farmer A, Holman R . Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63). BMJ. 2002; 325(7369):860. PMC: 129631. DOI: 10.1136/bmj.325.7369.860. View

17.

Glasgow R, Anderson R . In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed. Diabetes Care. 1999; 22(12):2090-2. DOI: 10.2337/diacare.22.12.2090. View

18.

Turner B, Hecht F . Improving on a coin toss to predict patient adherence to medications. Ann Intern Med. 2001; 134(10):1004-6. DOI: 10.7326/0003-4819-134-10-200105150-00015. View

19.

Zhang Q, Safford M, Ottenweller J, HAWLEY G, Repke D, Burgess Jr J . Performance status of health care facilities changes with risk adjustment of HbA1c. Diabetes Care. 2000; 23(7):919-27. DOI: 10.2337/diacare.23.7.919. View

20.

Richardson W, Berwick D, Bisgard J . The Institute of Medicine report on medical errors. N Engl J Med. 2000; 343(9):663-4; author reply 665. View